05/13/2024 3:54 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form S-1/A | |
05/13/2024 7:05 AM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 1:42 PM | METEORA CAPITAL, LLC (Filed by) NKGen Biotech, Inc. (Subject) NKGen Biotech (Subject) NKGen Biotech, Inc. (Subject)
| Form SC 13G/A | |
04/29/2024 4:20 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 10-K/A | |
04/16/2024 2:07 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/11/2024 7:05 AM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 3:55 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
03/15/2024 4:02 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:11 PM | Klowden Michael (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:14 PM | Gagnon Pierre (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:16 PM | NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer) Song Paul Y. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:19 PM | Kim Yong Man (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:20 PM | NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer) Scott Kathleen D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 12:05 PM | METEORA CAPITAL, LLC (Filed by) NKGen Biotech, Inc. (Subject) NKGen Biotech (Subject) NKGen Biotech, Inc. (Subject)
| Form SC 13G | |
02/14/2024 5:28 AM | NKGen Biotech, Inc. (Subject) NKGen Biotech (Subject) NKGen Biotech, Inc. (Subject) Radcliffe Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024 8:25 AM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/08/2024 4:07 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/07/2024 6:31 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) NKGen Biotech, Inc. (Subject) NKGen Biotech (Subject) NKGen Biotech, Inc. (Subject)
| Form SC 13G/A | |
01/22/2024 5:12 AM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 6:50 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 4:19 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 3:14 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2023 12:41 PM | NKGen Biotech, Inc. (Subject) NKGen Biotech (Subject) NKGen Biotech, Inc. (Subject) NKMAX Co., Ltd. (Filed by)
| Form SC 13D/A | |
12/15/2023 8:02 PM | NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer) NKMAX Co., Ltd. (Reporting) Park Sangwoo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:44 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form S-1/A | |
12/07/2023 4:23 PM | NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer) Song Paul Y. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 2:50 PM | Graf Acquisition Partners IV LLC (Reporting) Graf James A (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 2:51 PM | NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer) Song Paul Y. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 4:30 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form S-1/A | |
11/22/2023 4:53 PM | NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer) Song Paul Y. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:55 PM | Graf Acquisition Partners IV LLC (Reporting) Graf James A (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 3:36 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2023 3:39 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/30/2023 7:05 AM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 7:05 AM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 4:23 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K/A | |
10/19/2023 4:27 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
10/10/2023 4:01 PM | NKGen Biotech, Inc. (Subject) NKGen Biotech (Subject) NKGen Biotech, Inc. (Subject) NKMAX Co., Ltd. (Filed by)
| Form SC 13D | |
10/10/2023 3:15 PM | Klowden Michael (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/05/2023 4:12 PM | NKGen Biotech, Inc. (Filer) NKGen Biotech (Filer) NKGen Biotech, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 5:10 AM | Graf Acquisition Partners IV LLC (Reporting) Graf James A (Reporting) NKGen Biotech, Inc. (Issuer) NKGen Biotech (Issuer) NKGen Biotech, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Invest in the "Trojan Horse" of Alzheimer's Treatment (Ad) This one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics. Click here and learn how you can invest in this incredible opportunity>>> |
09/29/2023 4:24 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 3:16 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form CERT | |
09/29/2023 2:11 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 11:03 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-A12B | |
09/22/2023 3:08 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 424B3 | |
09/22/2023 11:55 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 11:55 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
09/22/2023 8:26 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 8:27 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
09/21/2023 6:31 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 424B3 | |
09/19/2023 2:51 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2023 2:52 PM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
09/18/2023 8:25 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 8:26 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
09/14/2023 8:30 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 8:31 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
09/11/2023 10:30 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 10:30 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
08/30/2023 6:30 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2023 6:30 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
08/24/2023 7:15 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
08/15/2023 3:30 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2023 3:31 PM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
08/14/2023 11:15 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form EFFECT | |
08/10/2023 1:09 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form S-4/A | |
08/09/2023 1:05 PM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
07/26/2023 10:54 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2023 10:55 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
07/17/2023 7:00 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 7:00 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
07/17/2023 5:01 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form S-4/A | |
07/06/2023 11:34 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
06/27/2023 12:37 PM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
06/26/2023 4:02 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form S-4/A | |
06/05/2023 7:30 AM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 7:32 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
05/31/2023 8:45 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 8:46 PM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |
05/23/2023 9:29 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject) Radcliffe Capital Management, L.P. (Filed by)
| Form SC 13G | |
05/22/2023 8:03 PM | Graf Acquisition Corp. IV (Filer) NKGen Biotech (Filer) Graf Acquisition Corp. IV (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2023 5:01 AM | Graf Acquisition Corp. IV (Subject) NKGen Biotech (Subject) Graf Acquisition Corp. IV (Subject)
| Form 425 | |